Research Article
N6-Methyladenosine (m6A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma
Figure 7
Exploring molecular mechanism and prediction of immunotherapy response in the entire set. (a) Enrichment level of immune cells, immune pathways, and immune function in the high- and low-subgroups. (b) Gene ontology (GO) enrichment analysis. The top 20 genes with mutation frequency between (c) the high-risk and (d) low-risk groups in the entire set. (e) TMB discrepancy between high-risk and low-risk groups. (f) TIDE scores discrepancy between high-risk and low-risk groups.
| (a) |
| (b) |
| (c) |
| (d) |
| (e) |
| (f) |